Long-Term Efficacy and Tolerability of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: A 24-Week Trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 4, p. s580, 2025. DOI: 10.25251/kdn30e02. Disponível em: https://skin.dermsquared.com/skin/article/view/3510. Acesso em: 12 nov. 2025.